Dr. Rohan Kalyan Rej received his Ph.D. in organic chemistry from the Indian Institute of Technology Kharagpur, India in 2015, followed by a postdoctoral fellowship at Purdue University, USA (2015–2016) and the University of Michigan, USA (2016–2020). He is currently a research-track faculty member at the University of Michigan, USA. His research interests mainly focus on the design and synthesis of novel anticancer drugs along with PROTAC degraders against different proteins.
Dr. Rohan Kalyan Rej received his Ph.D. in organic chemistry from the Indian Institute of Technology Kharagpur, India in 2015, followed by a postdoctoral fellowship at Purdue University, USA (2015–2016) and the University of Michigan, USA (2016–2020). He is currently a research-track faculty member at the University of Michigan, USA. His research interests mainly focus on the design and synthesis of novel anticancer drugs along with PROTAC degraders against different proteins.